Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC5A2 | P31639 | 18/20 | 0.47 |
| ▸ | SLC5A1 | P13866 | 9/20 | 0.46 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1457454 | 0.92 | SLC5A2 (0.40) | SLC5A2SLC5A1S1PR3 | |
| SCHEMBL2867610 | 0.89 | SLC5A2 (0.50) | SLC5A2SLC5A1 | |
| SCHEMBL3800313 | 0.86 | SLC5A2 (0.40) | SLC5A2SLC5A1 | |
| SCHEMBL3800305 | 0.86 | SLC5A2 (0.40) | SLC5A2SLC5A1 | |
| SCHEMBL2872402 | 0.85 | SLC5A2 (0.47) | SLC5A2SLC5A1 | |
| SCHEMBL1035412 | 0.84 | SLC5A2 (0.50) | SLC5A2SLC5A1 | |
| SCHEMBL29940875 | 0.84 | SLC5A2 (0.50) | SLC5A2SLC5A1 | |
| SCHEMBL499751 | 0.81 | SLC5A2 (0.40) | SLC5A2SLC5A1 | |
| SCHEMBL20139485 | 0.81 | SLC5A2 (0.40) | SLC5A2SLC5A1 | |
| SCHEMBL2865765 | 0.81 | SLC5A2 (0.59) | SLC5A2SLC5A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10442795-B2 | Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives and intermediates therein | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2019-10-15 | — | — | US | disclosed |
| EP-1881990-B1 | PROCESSES FOR PREPARING OF GLUCOPYRANOSYL-SUBSTITUTED BENZYL-BENZENE DERIVATIVES AND INTERMEDIATES THEREIN | BOEHRINGER INGELHEIM INT (DE) | 2016-02-17 | — | — | EP | disclosed |
| US-20150322053-A1 | PROCESSES FOR PREPARING OF GLUCOPYRANOSYL-SUBSTITUTED BENZYL-BENZENE DERIVATIVES AND INTERMEDIATES THEREIN | BOEHRINGER INGELHEIM INT (DE) | 2015-11-12 | — | — | US | disclosed |
| US-9127034-B2 | Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivates and intermediates therein | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2015-09-08 | — | — | US | disclosed |
| US-20100240879-A1 | PROCESSES FOR PREPARING OF GLUCOPYRANOSYL-SUBSTITUTED BENZYL-BENZENE DERIVATES AND INTERMEDIATES THEREIN | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2010-09-23 | — | — | US | disclosed |
| US-7772191-B2 | Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives and intermediates therein | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2010-08-10 | — | — | US | disclosed |
| EP-1881990-A1 | PROCESSES FOR PREPARING OF GLUCOPYRANOSYL-SUBSTITUTED BENZYL-BENZENE DERIVATIVES AND INTERMEDIATES THEREIN | Boehringer Ingelheim International GmbH (DE) | 2008-01-30 | — | — | EP | disclosed |
| WO-2006120208-A1 | PROCESSES FOR PREPARING OF GLUCOPYRANOSYL-SUBSTITUTED BENZYL-BENZENE DERIVATIVES AND INTERMEDIATES THEREIN | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2006-11-16 | — | — | WO | disclosed |
| US-20060258749-A1 | Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives and intermediates therein | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2006-11-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060258749-A1 | Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives and intermediates therein | UGGT1, B3GAT3, B4GALT1 | SLC5A2 120/4885SLC5A1 111/4885S1PR3 2281/4885 |
| US-20100240879-A1 | PROCESSES FOR PREPARING OF GLUCOPYRANOSYL-SUBSTITUTED BENZYL-BENZENE DERIVATES AND INTERMEDIATES THEREIN | UGGT1, B3GAT3, B4GALT1 | SLC5A2 123/4885SLC5A1 85/4885S1PR3 1965/4885 |
| US-10442795-B2 | Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives and intermediates therein | UGGT1, B3GAT3, B4GALT1 | SLC5A2 120/4885SLC5A1 111/4885S1PR3 2281/4885 |
| US-20150322053-A1 | PROCESSES FOR PREPARING OF GLUCOPYRANOSYL-SUBSTITUTED BENZYL-BENZENE DERIVATIVES AND INTERMEDIATES THEREIN | UGGT1, B3GAT3, B4GALT1 | SLC5A2 120/4885SLC5A1 111/4885S1PR3 2281/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.